Medical Innovation Exchange

Pfizer's hemophilia B gene therapy is better than standard of care in phase 3 trial

https://www.fiercebiotech.com/biotech/pfizers-hemophilia-b-gene-therapy-better-standard-care-phase-3-trial

Leave a Comment

Your email address will not be published. Required fields are marked *

Leave the field below empty!